OssDsign entered commercial partnerships covering distribution of its products for cranial repair and facial bone reconstruction in Italy, Spain, Switzerland, Austria and The Netherlands.
OSSDSIGN® Cranial and OSSDSIGN® Facial are presently marketed in Germany, the U.K. and the Nordic region, as well as select non-EU markets including Singapore and Israel.
The company is preparing for U.S. product launch in 1Q17, and is also pursuing regulatory and commercial activities in Japan.
OssDsign (formerly Oss-Q) has developed a bioceramic material with a chemical composition similar to bone, with a focus on cranial surgery and future applications in fracture healing.
OssDsign entered commercial partnerships covering distribution of its products for cranial repair and facial bone reconstruction in Italy, Spain, Switzerland, Austria and The Netherlands.
OSSDSIGN® Cranial and OSSDSIGN® Facial are presently marketed in Germany, the U.K. and the Nordic region, as well as select non-EU markets including...
OssDsign entered commercial partnerships covering distribution of its products for cranial repair and facial bone reconstruction in Italy, Spain, Switzerland, Austria and The Netherlands.
OSSDSIGN® Cranial and OSSDSIGN® Facial are presently marketed in Germany, the U.K. and the Nordic region, as well as select non-EU markets including Singapore and Israel.
The company is preparing for U.S. product launch in 1Q17, and is also pursuing regulatory and commercial activities in Japan.
OssDsign (formerly Oss-Q) has developed a bioceramic material with a chemical composition similar to bone, with a focus on cranial surgery and future applications in fracture healing.
Copy to clipboard 
